Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 480 entries
Sorted by: Best Match Show Resources per page
The Me.

Chemistry (Weinheim an der Bergstrasse, Germany)

Bertocco P, Bolli C, Derendorf J, Jenne C, Klein A, Stirnat K.
PMID: 27704626
Chemistry. 2016 Nov 02;22(45):16032-16036. doi: 10.1002/chem.201603924. Epub 2016 Oct 05.

Strong oxidizing agents often contain fluorine and are not compatible with substrates forming strong element-fluorine bonds. Therefore, there is need for new strong oxidizers. Cyclic voltammetric measurements on the weakly coordinating anion [Me

Cite
Bertocco P, Bolli C, Derendorf J, et al. The Me. Chemistry. 2016;22(45):16032-16036doi: 10.1002/chem.201603924.
Bertocco, P., Bolli, C., Derendorf, J., Jenne, C., Klein, A., & Stirnat, K. (2016). The Me. Chemistry (Weinheim an der Bergstrasse, Germany), 22(45), 16032-16036. https://doi.org/10.1002/chem.201603924
Bertocco, Philipp, et al. "The Me." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 22,45 (2016): 16032-16036. doi: https://doi.org/10.1002/chem.201603924
Bertocco P, Bolli C, Derendorf J, Jenne C, Klein A, Stirnat K. The Me. Chemistry. 2016 Nov 02;22(45):16032-16036. doi: 10.1002/chem.201603924. Epub 2016 Oct 05. PMID: 27704626.
Copy Download .nbib Format: NLM
Reaction of the Tricyanoborate Dianion [B(CN).

Inorganic chemistry

Bernhardt E, Bernhardt-Pitchougina V, Jenne C.
PMID: 28425700
Inorg Chem. 2017 May 01;56(9):5465-5470. doi: 10.1021/acs.inorgchem.7b00541. Epub 2017 Apr 20.

The very reactive [B(CN)

Cite
Bernhardt E, Bernhardt-Pitchougina V, Jenne C. Reaction of the Tricyanoborate Dianion [B(CN). Inorg Chem. 2017;56(9):5465-5470doi: 10.1021/acs.inorgchem.7b00541.
Bernhardt, E., Bernhardt-Pitchougina, V., & Jenne, C. (2017). Reaction of the Tricyanoborate Dianion [B(CN). Inorganic chemistry, 56(9), 5465-5470. https://doi.org/10.1021/acs.inorgchem.7b00541
Bernhardt, Eduard, et al. "Reaction of the Tricyanoborate Dianion [B(CN)." Inorganic chemistry vol. 56,9 (2017): 5465-5470. doi: https://doi.org/10.1021/acs.inorgchem.7b00541
Bernhardt E, Bernhardt-Pitchougina V, Jenne C. Reaction of the Tricyanoborate Dianion [B(CN). Inorg Chem. 2017 May 01;56(9):5465-5470. doi: 10.1021/acs.inorgchem.7b00541. Epub 2017 Apr 20. PMID: 28425700.
Copy Download .nbib Format: NLM
Large genetic screens for gynogenesis and androgenesis haploid inducers in Arabidopsis thaliana failed to identify mutants.

Frontiers in plant science

Portemer V, Renne C, Guillebaux A, Mercier R.
PMID: 25814999
Front Plant Sci. 2015 Mar 12;6:147. doi: 10.3389/fpls.2015.00147. eCollection 2015.

Gynogenesis is a process in which the embryo genome originates exclusively from female origin, following embryogenesis stimulation by a male gamete. In contrast, androgenesis is the development of embryos that contain only the male nuclear genetic background. Both phenomena...

Cite
Portemer V, Renne C, Guillebaux A, et al. Large genetic screens for gynogenesis and androgenesis haploid inducers in Arabidopsis thaliana failed to identify mutants. Front Plant Sci. 2015;6:147doi: 10.3389/fpls.2015.00147.
Portemer, V., Renne, C., Guillebaux, A., & Mercier, R. (2015). Large genetic screens for gynogenesis and androgenesis haploid inducers in Arabidopsis thaliana failed to identify mutants. Frontiers in plant science, 6147. https://doi.org/10.3389/fpls.2015.00147
Portemer, Virginie, et al. "Large genetic screens for gynogenesis and androgenesis haploid inducers in Arabidopsis thaliana failed to identify mutants." Frontiers in plant science vol. 6 (2015): 147. doi: https://doi.org/10.3389/fpls.2015.00147
Portemer V, Renne C, Guillebaux A, Mercier R. Large genetic screens for gynogenesis and androgenesis haploid inducers in Arabidopsis thaliana failed to identify mutants. Front Plant Sci. 2015 Mar 12;6:147. doi: 10.3389/fpls.2015.00147. eCollection 2015. PMID: 25814999; PMCID: PMC4357253.
Copy Download .nbib Format: NLM
Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates.

Molecular therapy. Methods & clinical development

Denard J, Jenny C, Blouin V, Moullier P, Svinartchouk F.
PMID: 26015972
Mol Ther Methods Clin Dev. 2014 Jul 30;1:14031. doi: 10.1038/mtm.2014.31. eCollection 2014.

Vectors based on recombinant adeno-associated viruses (rAAV) attract a growing interest for human gene therapy. Recently, it was shown that many rAAV serotypes produced by transient transfection of human embryonic kidney 293 cell line (HEK293) are efficiently released into...

Cite
Denard J, Jenny C, Blouin V, et al. Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates. Mol Ther Methods Clin Dev. 2014;1:14031doi: 10.1038/mtm.2014.31.
Denard, J., Jenny, C., Blouin, V., Moullier, P., & Svinartchouk, F. (2014). Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates. Molecular therapy. Methods & clinical development, 114031. https://doi.org/10.1038/mtm.2014.31
Denard, Jerome, et al. "Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates." Molecular therapy. Methods & clinical development vol. 1 (2014): 14031. doi: https://doi.org/10.1038/mtm.2014.31
Denard J, Jenny C, Blouin V, Moullier P, Svinartchouk F. Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates. Mol Ther Methods Clin Dev. 2014 Jul 30;1:14031. doi: 10.1038/mtm.2014.31. eCollection 2014. PMID: 26015972; PMCID: PMC4362353.
Copy Download .nbib Format: NLM
Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks.

Clinical obesity

Rolland C, Lula S, Jenner C, Dyson L, Macdonald I, Johnston KL, Broom I.
PMID: 25586630
Clin Obes. 2013 Oct;3(5):150-7. doi: 10.1111/cob.12029. Epub 2013 Aug 23.

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Approximately 80% of people with type 2 diabetes mellitus (T2DM) are overweight or obese. Weight loss produces numerous benefits in T2DM. People with T2DM have difficulty losing and maintaining weight.WHAT THIS STUDY...

Cite
Rolland C, Lula S, Jenner C, et al. Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clin Obes. 2013;3(5):150-7doi: 10.1111/cob.12029.
Rolland, C., Lula, S., Jenner, C., Dyson, L., Macdonald, I., Johnston, K. L., & Broom, I. (2013). Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clinical obesity, 3(5), 150-7. https://doi.org/10.1111/cob.12029
Rolland, C, et al. "Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks." Clinical obesity vol. 3,5 (2013): 150-7. doi: https://doi.org/10.1111/cob.12029
Rolland C, Lula S, Jenner C, Dyson L, Macdonald I, Johnston KL, Broom I. Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clin Obes. 2013 Oct;3(5):150-7. doi: 10.1111/cob.12029. Epub 2013 Aug 23. PMID: 25586630.
Copy Download .nbib Format: NLM
Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.

PloS one

Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, MacDonald ME, Gusella JF, Chen JF, Akbarian S, Weng Z, Myers RH.
PMID: 27454300
PLoS One. 2016 Jul 25;11(7):e0160295. doi: 10.1371/journal.pone.0160295. eCollection 2016.

[This corrects the article DOI: 10.1371/journal.pone.0143563.].

Cite
Labadorf A, Hoss AG, Lagomarsino V, et al. Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PLoS One. 2016;11(7):e0160295doi: 10.1371/journal.pone.0160295.
Labadorf, A., Hoss, A. G., Lagomarsino, V., Latourelle, J. C., Hadzi, T. C., Bregu, J., MacDonald, M. E., Gusella, J. F., Chen, J. F., Akbarian, S., Weng, Z., & Myers, R. H. (2016). Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PloS one, 11(7), e0160295. https://doi.org/10.1371/journal.pone.0160295
Labadorf, Adam, et al. "Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression." PloS one vol. 11,7 (2016): e0160295. doi: https://doi.org/10.1371/journal.pone.0160295
Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, MacDonald ME, Gusella JF, Chen JF, Akbarian S, Weng Z, Myers RH. Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PLoS One. 2016 Jul 25;11(7):e0160295. doi: 10.1371/journal.pone.0160295. eCollection 2016. PMID: 27454300; PMCID: PMC4959683.
Copy Download .nbib Format: NLM
Improving the Solubility of Halogenated 1-Ammonio-closo-dodecaborate Anions.

Inorganic chemistry

Bertocco P, Derendorf J, Jenne C, Kirsch C.
PMID: 28240900
Inorg Chem. 2017 Mar 20;56(6):3459-3466. doi: 10.1021/acs.inorgchem.6b03006. Epub 2017 Feb 27.

The partly halogenated and N-alkylated closo-dodecaborates [B

Cite
Bertocco P, Derendorf J, Jenne C, et al. Improving the Solubility of Halogenated 1-Ammonio-closo-dodecaborate Anions. Inorg Chem. 2017;56(6):3459-3466doi: 10.1021/acs.inorgchem.6b03006.
Bertocco, P., Derendorf, J., Jenne, C., & Kirsch, C. (2017). Improving the Solubility of Halogenated 1-Ammonio-closo-dodecaborate Anions. Inorganic chemistry, 56(6), 3459-3466. https://doi.org/10.1021/acs.inorgchem.6b03006
Bertocco, Philipp, et al. "Improving the Solubility of Halogenated 1-Ammonio-closo-dodecaborate Anions." Inorganic chemistry vol. 56,6 (2017): 3459-3466. doi: https://doi.org/10.1021/acs.inorgchem.6b03006
Bertocco P, Derendorf J, Jenne C, Kirsch C. Improving the Solubility of Halogenated 1-Ammonio-closo-dodecaborate Anions. Inorg Chem. 2017 Mar 20;56(6):3459-3466. doi: 10.1021/acs.inorgchem.6b03006. Epub 2017 Feb 27. PMID: 28240900.
Copy Download .nbib Format: NLM
Selected-ion flow tube temperature-dependent measurements for the reactions of O₂⁺ with N atoms and N₂⁺ with O atoms.

The Journal of chemical physics

Martinez O, Sanchez JC, Ard SG, Li A, Melko JJ, Shuman NS, Guo H, Viggiano AA.
PMID: 25903888
J Chem Phys. 2015 Apr 21;142(15):154305. doi: 10.1063/1.4916913.

The temperature variation of rate constants has been measured for the gas phase reactions of the oxycation O2(+) with N atoms and of N2(+) with O atoms from 120 to 400 K using a variable temperature-selected ion flow tube....

Cite
Martinez O, Sanchez JC, Ard SG, et al. Selected-ion flow tube temperature-dependent measurements for the reactions of O₂⁺ with N atoms and N₂⁺ with O atoms. J Chem Phys. 2015;142(15):154305doi: 10.1063/1.4916913.
Martinez, O., Sanchez, J. C., Ard, S. G., Li, A., Melko, J. J., Shuman, N. S., Guo, H., & Viggiano, A. A. (2015). Selected-ion flow tube temperature-dependent measurements for the reactions of O₂⁺ with N atoms and N₂⁺ with O atoms. The Journal of chemical physics, 142(15), 154305. https://doi.org/10.1063/1.4916913
Martinez, Oscar, et al. "Selected-ion flow tube temperature-dependent measurements for the reactions of O₂⁺ with N atoms and N₂⁺ with O atoms." The Journal of chemical physics vol. 142,15 (2015): 154305. doi: https://doi.org/10.1063/1.4916913
Martinez O, Sanchez JC, Ard SG, Li A, Melko JJ, Shuman NS, Guo H, Viggiano AA. Selected-ion flow tube temperature-dependent measurements for the reactions of O₂⁺ with N atoms and N₂⁺ with O atoms. J Chem Phys. 2015 Apr 21;142(15):154305. doi: 10.1063/1.4916913. PMID: 25903888.
Copy Download .nbib Format: NLM
Protic anions [H(B12X12)]- (X = F, Cl, Br, I) that act as Brønsted acids in the gas phase.

Chemistry (Weinheim an der Bergstrasse, Germany)

Jenne C, Keßler M, Warneke J.
PMID: 25735766
Chemistry. 2015 Apr 07;21(15):5887-91. doi: 10.1002/chem.201500034. Epub 2015 Mar 03.

The acidity of protic cations and neutral molecules has been studied extensively in the gas phase, and the gas-phase acidity has been established previously as a very useful measure of the intrinsic acidity of neutral and cationic compounds. However,...

Cite
Jenne C, Keßler M, Warneke J. Protic anions [H(B12X12)]- (X = F, Cl, Br, I) that act as Brønsted acids in the gas phase. Chemistry. 2015;21(15):5887-91doi: 10.1002/chem.201500034.
Jenne, C., Keßler, M., & Warneke, J. (2015). Protic anions [H(B12X12)]- (X = F, Cl, Br, I) that act as Brønsted acids in the gas phase. Chemistry (Weinheim an der Bergstrasse, Germany), 21(15), 5887-91. https://doi.org/10.1002/chem.201500034
Jenne, Carsten, et al. "Protic anions [H(B12X12)]- (X = F, Cl, Br, I) that act as Brønsted acids in the gas phase." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,15 (2015): 5887-91. doi: https://doi.org/10.1002/chem.201500034
Jenne C, Keßler M, Warneke J. Protic anions [H(B12X12)]- (X = F, Cl, Br, I) that act as Brønsted acids in the gas phase. Chemistry. 2015 Apr 07;21(15):5887-91. doi: 10.1002/chem.201500034. Epub 2015 Mar 03. PMID: 25735766.
Copy Download .nbib Format: NLM
CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma.

Frontiers in oncology

Löffek S, Ullrich N, Görgens A, Murke F, Eilebrecht M, Menne C, Giebel B, Schadendorf D, Singer BB, Helfrich I.
PMID: 26539411
Front Oncol. 2015 Oct 19;5:234. doi: 10.3389/fonc.2015.00234. eCollection 2015.

Widespread metastasis is the leading course of death in many types of cancer, including malignant melanoma. The process of metastasis can be divided into a number of complex cell biological events, collectively termed the "invasion-metastasis cascade." Previous reports have...

Cite
Löffek S, Ullrich N, Görgens A, et al. CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma. Front Oncol. 2015;5:234doi: 10.3389/fonc.2015.00234.
Löffek, S., Ullrich, N., Görgens, A., Murke, F., Eilebrecht, M., Menne, C., Giebel, B., Schadendorf, D., Singer, B. B., & Helfrich, I. (2015). CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma. Frontiers in oncology, 5234. https://doi.org/10.3389/fonc.2015.00234
Löffek, Stefanie, et al. "CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma." Frontiers in oncology vol. 5 (2015): 234. doi: https://doi.org/10.3389/fonc.2015.00234
Löffek S, Ullrich N, Görgens A, Murke F, Eilebrecht M, Menne C, Giebel B, Schadendorf D, Singer BB, Helfrich I. CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma. Front Oncol. 2015 Oct 19;5:234. doi: 10.3389/fonc.2015.00234. eCollection 2015. PMID: 26539411; PMCID: PMC4609850.
Copy Download .nbib Format: NLM
An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support. .

Angewandte Chemie (International ed. in English)

Piganeau N, Jenne A, Thuillier V, Famulok M.
PMID: 11592180
Angew Chem Int Ed Engl. 2001 Oct 01;40(19):3503. doi: 10.1002/1521-3773(20011001)40:19<3503::aid-anie11113503>3.0.co;2-3.

No abstract available.

Cite
Piganeau N, Jenne A, Thuillier V, et al. An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support. . Angew Chem Int Ed Engl. 2001;40(19):3503doi: 10.1002/1521-3773(20011001)40:19<3503::aid-anie11113503>3.0.co;2-3.
Piganeau, N., Jenne, A., Thuillier, V., & Famulok, M. (2001). An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support. . Angewandte Chemie (International ed. in English), 40(19), 3503. https://doi.org/10.1002/1521-3773(20011001)40:19<3503::aid-anie11113503>3.0.co;2-3
Piganeau, Nicolas, et al. "An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support. ." Angewandte Chemie (International ed. in English) vol. 40,19 (2001): 3503. doi: https://doi.org/10.1002/1521-3773(20011001)40:19<3503::aid-anie11113503>3.0.co;2-3
Piganeau N, Jenne A, Thuillier V, Famulok M. An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support. . Angew Chem Int Ed Engl. 2001 Oct 01;40(19):3503. doi: 10.1002/1521-3773(20011001)40:19<3503::aid-anie11113503>3.0.co;2-3. PMID: 11592180.
Copy Download .nbib Format: NLM
Recognizing and responding to medical neglect.

Pediatrics

Jenny C.
PMID: 18055690
Pediatrics. 2007 Dec;120(6):1385-9. doi: 10.1542/peds.2007-2903.

A caregiver may fail to recognize or respond to a child's medical needs for a variety of reasons. An effective response by a health care professional to medical neglect requires a comprehensive assessment of the child's needs, the parents'...

Cite
Jenny C. Recognizing and responding to medical neglect. Pediatrics. 2007;120(6):1385-9doi: 10.1542/peds.2007-2903.
Jenny, C. (2007). Recognizing and responding to medical neglect. Pediatrics, 120(6), 1385-9. https://doi.org/10.1542/peds.2007-2903
Jenny, Carole. "Recognizing and responding to medical neglect." Pediatrics vol. 120,6 (2007): 1385-9. doi: https://doi.org/10.1542/peds.2007-2903
Jenny C. Recognizing and responding to medical neglect. Pediatrics. 2007 Dec;120(6):1385-9. doi: 10.1542/peds.2007-2903. PMID: 18055690.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 480 entries